Roche gets FDA approval for ZIIHERA companion diagnostics
Roche has received FDA approval for companion diagnostic tests identifying patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.